Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Pablo Pergola
Efficacy and Safety of Sparsentan Compared With Irbesartan in Patients With Primary Focal Segmental Glomerulosclerosis: Randomized, Controlled Trial Design (DUET)
Kidney International Reports
Nephrology
Related publications
A Phase 2, Double-Blind, Placebo-Controlled, Randomized Study of Fresolimumab in Patients With Steroid-Resistant Primary Focal Segmental Glomerulosclerosis
Kidney International Reports
Nephrology
Urinary Prognostic Biomarkers in Patients With Focal Segmental Glomerulosclerosis
Nephro-Urology Monthly
Urology
Primary Focal Segmental Glomerulosclerosis: miRNAs and Targeted Therapies
European Journal of Clinical Investigation
Medicine
Biochemistry
Clinical Biochemistry
Urinary Soluble Urokinase Receptor Levels Are Elevated and Pathogenic in Patients With Primary Focal Segmental Glomerulosclerosis
BMC Medicine
Medicine
Focal Segmental Glomerulosclerosis
American Journal of Medicine
Medicine
Rituximab Treatment of Adult Patients With Steroid-Resistant Focal Segmental Glomerulosclerosis
Clinical Journal of the American Society of Nephrology
Epidemiology
Nephrology
Critical Care
Transplantation
Intensive Care Medicine
Efficacy and Safety of Diacerein in Patients With Inadequately Controlled Type 2 Diabetes: A Randomized Controlled Trial
Diabetes Care
Internal Medicine
Endocrinology
Advanced
Metabolism
Specialized Nursing
Diabetes
Genetics of Focal Segmental Glomerulosclerosis
Pediatric Nephrology
Child Health
Pediatrics
Perinatology
Nephrology
NPHS2variation in Focal and Segmental Glomerulosclerosis
BMC Nephrology
Nephrology
